Pharma Major Cipla
Acquires Ivia Beaute

Pharma Major Cipla Acquires Ivia Beaute

Cipla Health Limited has entered into a significant business transfer agreement, acquiring the distribution and marketing operations of Ivia Beaute Private Ltd’s cosmetics and personal care business in India. The acquisition, valued at ₹130 crores upon closure, includes an additional ₹110 crores contingent upon meeting specified financial milestones over the next three years.

This strategic move encompasses the global ownership of IVIA’s brands, including Astaberry, Ikin, and Bhimsaini. Cipla Health, a subsidiary of pharmaceutical giant Cipla, emphasizes that this acquisition aligns with its strategic focus on bolstering its consumer healthcare and wellness portfolio.

With a rich heritage spanning over 16 years, Astaberry stands as a cornerstone in skincare, catering to diverse consumer needs. Cipla Health highlights that this acquisition fortifies its presence in the beauty and personal care sector, complementing its existing offerings in skincare.

Shivam Puri, CEO and Whole Time Director of Cipla Health Limited, expressed enthusiasm about the acquisition, stating, “This move not only solidifies our presence in the expansive and dynamic beauty and personal care sector but also builds on our well-established footprint in Tier 2-6 cities.”

Subscribe to our free newsletter to read the latest news and articles before they are published.